ArticleCancer chemotherapy and pharmacology2024

Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors.

Noboru Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.